Mylan to Refund Covered Entities for EpiPen Overcharges
Mylan will refund 340B covered entities a total of $19.3 million for overcharges on the EpiPen as part of its recent settlement agreement with the Department of Justice resolving claims…
340B Database Will Be Temporarily Unavailable
The OPA 340B database will be unavailable from August 15, 2017 through mid-September 2017 as HRSA transitions to a new database system. During this time, covered entities will not be…
Recent GAO Report on 340B Program Oversight
The Government Accountability Office (GAO) submitted a report on 340B program oversight as part of its testimony during the House Energy and Commerce’s Subcommittee on Oversight and Investigations hearing on…
AIR340B Senate Briefing Documents
Here is a copy of the materials that the Alliance for Integrity and Reform of 340B (AIR-340B) shared with attendees at its Hill briefing on July 17, 2017. AIR-340B continues…